RIYADH, Saudi Arabia, Oct. 24, 2022 /CNW/ — iGan Arabia* is pleased to announce that two of its leading portfolio companies have been selected to present at the upcoming flagship FII conference taking place this week in Riyadh.
Over the course of three days with more than 500 International speakers, the conference will host four immersive summits and 180 sessions led by global leaders. Six thousand delegates will address the most pressing economic questions of our time to shape the future of the global economy. Moleculight and Retispec have been selected by FII to showcase their products as key innovations addressing important healthcare challenges for the region.
Moleculight has developed the first-ever wound assessment device to provide real-time imaging of bacteria distribution at the point of care. MolecuLight i:X® and DX™ imaging systems are point-of-care handheld imaging devices for the real-time detection and localization of bacterial load in wounds and digital wound measurement. The Company has seen a 240% increase in 12-week wound healing rates – doubling the current standard of care.
Retispec is an AI-Imaging company focused on early detection of neurodegenerative diseases through a simple eye exam. The Company recently announced the launch of a unique initiative to screen for Alzheimer’s disease in community settings and is backed by the Davos Alzheimer’s Collaborative (DAC). Retispec was One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer’s Collaborative Grant Program for Healthcare System Preparedness.
This year was the most competitive on record for the FII technology partnership program with more than 80 companies in the selection process representing the best of global innovation. Both Moleculight and Retispec were chosen for their disruptive solutions that will improve patient outcomes while lowering overall healthcare costs.
About iGan Arabia:
iGan is launching iGan Arabia* which is a US$250M regional fund to drive MedTech innovation across the Middle East and North Africa region. The Fund is investing in AI/Cloud-enhanced medical devices and digital health technologies and will help accelerate the GCC as a world-class MedTech hub. The Fund will be launched by iGan Partners, Canada’s leading healthcare technology investors and Faisal Belhoul, a Dubai-based investments professional and entrepreneur.
*subject to ADGM approval